Q32 Bio Inc. · GETTEX:DB0

Q32 Bio Inc. financial statements

Q32 Bio Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue53.7M0-6.65M3.21M34.0M2.70M1.67M3.68M
Cost of revenue391.0K487.0K499.0K2.60M9.54M684.2K239.8K
Gross profit53.7M-487.0K-6.65M6.65M24.4M2.70M1.67M5.32M-684.2K-239.8K
Research and development19.2M48.1M31.7M98.4M93.1M100.4M89.4M47.9M21.4M5.69M
Selling, general and administrative17.7M18.0M9.88M10.1M6.76M
Operating income16.9M-66.1M-48.3M-133.3M-95.9M-130.3M-109.9M-59.9M-29.7M-10.0M
Depreciation and amortization391.0K487.0K499.0K1.29M8.35M7.96M6.32M1.29M684.0K239.8K
EBITDA17.3M-65.6M-47.8M-132.0M-87.6M-122.3M-103.6M-58.6M-29.0M-9.76M
Interest expense1.10M1.10M1.50M
Income before tax29.8M-46.1M-87.1M1.20M-95.8M-128.7M-103.9M-55.6M-30.0M-8.05M
Income tax021.0K318.0K715.0K000002
Net income29.8M-47.7M-53.7M-5.00M-95.8M-128.7M-103.9M-55.6M-30.0M-8.05M
Earnings per share, basic2.42-5.12-153.96-0.09-1.73-2.80-2.47-1.95-12.10-3.87
Earnings per share, diluted2.42-6.58-153.96-0.09-1.73-2.80-2.47-1.95-12.10

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents48.3M78.0M25.6M34.0M108.4M217.4M53.8M38.2M51.6M11.4M
Short-term investments00141.0M47.5M0208.6M176.5M78.1M
Receivables555.0K755.0K1.06M909.0K400.0K400.0K800.0K113.3K
Inventory1.75M769.0K1
Current assets55.0M81.9M28.7M181.0M191.9M219.6M266.6M221.7M131.6M12.0M
Property, plant and equipment979.0K1.37M1.78M1.08M2.25M37.0M42.7M35.6M3.15M
Total assets61.8M92.3M47.1M228.5M211.7M263.7M310.6M259.1M137.5M14.2M
Accounts payable879.0K2.99M3.47M1.14M2.37M4.72M2.61M15.7M2.54M893.7K
Current liabilities11.3M16.5M14.1M22.6M17.2M22.7M12.4M22.5M8.86M6.38M
Long-term debt3.47M9.56M43.2M5.07M4.97M
Total debt15.3M18.9M50.8M29.9M23.9M15.4M
Total liabilities19.8M86.7M118.5M50.5M42.1M67.7M52.1M62.7M39.2M6.72M
Shareholders' equity42.0M5.67M-182.9M-130.7M169.7M196.0M258.5M196.4M-39.5M7.50M
Shares outstanding12.9M12.2M359.6K57.5M57.2M50.3M45.1M37.4M2.64M2.08M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-33.5M-67.7M-18.7M-113.7M-109.8M-94.3M-91.4M-42.6M6.48M-8.48M
Capital spending0-75.0K-5.00K-1.28M-2.40M-3.73M-21.8M-24.9M-1.96M-1.99M
Free cash flow-33.5M-67.8M-18.7M-114.9M-112.1M-98.1M-113.2M-67.5M4.52M-10.5M
Cash from investing7.00M19.9M-5.00K36.7M-50.8M204.9M-51.8M-121.8M-81.5M-2.27M
Cash from financing-3.13M95.1M406.0K596.0K52.2M53.1M158.2M151.0M115.2M378.3K
Share buybacks-17.5K
Change in cash-29.7M47.3M5.28M-76.3M-108.4M163.7M15.1M-13.4M40.2M-10.4M